1. Abood, A, Vestergaard, P: Increasing incidence of primary hyperparathyroidism in Denmark. Dan Med J 2013;60(2):A4567.
Google Scholar | Medline2. Thier, M, Nordenstrom, E, Bergenfelz, A, et al: Presentation and outcomes after surgery for primary hyperparathyroidism during an 18-year period. World J Surg 2016;40:356–364.
Google Scholar | Crossref | Medline3. Kluijfhout, WP, Pasternak, JD, Drake, FT, et al: Use of PET tracers for parathyroid localization: A systematic review and meta-analysis. Langenbecks Arch Surg 2016;401(7):925–935.
Google Scholar | Crossref | Medline4. Beggs, AD, Hain, SF: Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun 2005;26(2):133–136.
Google Scholar | Crossref | Medline5. Braeuning, U, Pfannenberg, C, Gallwitz, B, et al: 11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism. Nuklearmedizin 2015;54(1):26–30.
Google Scholar | Crossref | Medline6. Chun, IK, Cheon, GJ, Paeng, JC, et al: Detection and characterization of parathyroid adenoma/hyperplasia for preoperative localization: Comparison between 11C-methionine PET/CT and 99mTc-sestamibi scintigraphy. Nucl Med Mol Imaging 2013;47:166–172.
Google Scholar | Crossref | Medline7. Comar, D, Cartron, J, Maziere, M, et al: Labelling and metabolism of methionine-methyl-11 C. Eur J Nucl Med 1976;1(1):11–14.
Google Scholar | Crossref | Medline8. Erbil, Y, Barbaros, U, Yanik, BT, et al: Impact of gland morphology and concomitant thyroid nodules on preoperative localization of parathyroid adenomas. Laryngoscope 2006;116(4):580–585.
Google Scholar | Crossref | Medline | ISI9. Lorberboym, M, Ezri, T, Schachter, PP: Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter. Arch Surg 2005;140(7):656–660.
Google Scholar | Crossref | Medline10. Pata, G, Casella, C, Besuzio, S, et al: Clinical appraisal of 99m technetium-sestamibi SPECT/CT compared to conventional SPECT in patients with primary hyperparathyroidism and concomitant nodular goiter. Thyroid 2010;20(10):1121–1127.
Google Scholar | Crossref | Medline11. Rasmussen, K, Larsen, LP, Arveschoug, A, et al: Predictive value of parathyroid scintigraphy in the preoperative evaluation of patients with primary hyperparathyroidism. Scand J Surg 2006;95(3):199–204.
Google Scholar | SAGE Journals | ISI12. Conti, M, Eriksson, L: Physics of pure and non-pure positron emitters for PET: A review and a discussion. EJNMMI Phys 2016;3(1):8.
Google Scholar | Crossref | Medline13. Jødal, L, Le Loirec, C, Champion, C: Positron range in PET imaging: An alternative approach for assessing and correcting the blurring. Phys Med Biol 2012;57:3931–3943.
Google Scholar | Crossref | Medline14. Fischli, S, Suter-Widmer, I, Nguyen, BT, et al: The significance of 18F-fluorocholine-PET/CT as localizing imaging technique in patients with primary hyperparathyroidism and negative conventional imaging. Front Endocrinol 2017;8:380.
Google Scholar | Crossref | Medline15. Kluijfhout, WP, Vorselaars, WM, van den Berk, SA, et al: Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: A multicenter study from the Netherlands. Nucl Med Commun 2016;37(12):1246–1252.
Google Scholar | Crossref | Medline16. Lezaic, L, Rep, S, Sever, MJ, et al: (1)(8)F-fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: A pilot study. Eur J Nucl Med Mol Imaging 2014;41:2083–2089.
Google Scholar | Crossref | Medline17. Michaud, L, Balogova, S, Burgess, A, et al: A pilot comparison of 18F-fluorocholine PET/CT, ultrasonography and 123I/99mTc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: Influence of thyroid anomalies. Medicine 2015;94(41):e1701.
Google Scholar | Medline18. Quak, E, Blanchard, D, Houdu, B, et al: F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: The APACH1 study. Eur J Nucl Med Mol Imaging 2018;45(4):658–666.
Google Scholar | Crossref | Medline19. Melon, P, Luxen, A, Hamoir, E, et al: Fluorine-18-fluoro-deoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995;22(6):556–558.
Google Scholar | Crossref | Medline20. Neumann, DR, Esselstyn, CB, MacIntyre, WJ, et al: Primary hyperparathyroidism: Preoperative parathyroid imaging with regional body FDG PET. Radiology 1994;192(2):509–512.
Google Scholar | Crossref | Medline21. Neumann, DR, Esselstyn, CB, MacIntyre, WJ, et al: Regional body FDG-PET in postoperative recurrent hyperparathyroidism. J Comput Assist Tomogr 1997;21(1):25–28.
Google Scholar | Crossref | Medline22. Neumann, DR, Esselstyn, CB, Maclntyre, WJ, et al: Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 1996;37(11):1809–1815.
Google Scholar | Medline23. Sisson, JC, Thompson, NW, Ackerman, RJ, et al: Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism. Radiology 1994;192(1):280.
Google Scholar | Crossref | Medline24. Andersen, TB, Aleksyniene, R, Boldsen, SK, et al: Contrast-enhanced computed tomography does not improve the diagnostic value of parathyroid dual-phase MIBI SPECT/CT. Nucl Med Commun 2018;39:435–440.
Google Scholar | Crossref | Medline25. Sandqvist, P, Nilsson, IL, Grybäck, P, et al: Multiphase iodine contrast-enhanced SPECT/CT outperforms nonenhanced SPECT/CT for preoperative localization of small parathyroid adenomas. Clin Nucl Med 2019;44(12):929–935.
Google Scholar | Crossref | Medline26. Komek, H, Yilmaz, EE, Cakabay, B, et al: Contrast enhanced [99mTc] MIBI SPECT/CT in primary hyperparathyroidism. Ann Ital Chir 2018;89:379–384.
Google Scholar | Medline27. Wan, QC, Li, JF, Tang, LL, et al: Comparing the diagnostic accuracy of 4D CT and 99mTc-MIBI SPECT/CT for localizing hyperfunctioning parathyroid glands: A systematic review and meta-analysis. Nucl Med Commun 2021;42:225–233.
Google Scholar | Crossref | Medline